New World Medical Achieves MDR Approval for Ahmed Glaucoma Valve and Other Innovative Products

New World Medical Achieves Important MDR Certification

On October 6, 2026, New World Medical announced a significant milestone by receiving Medical Device Regulation (MDR) certification in the European Union for its Ahmed Glaucoma Valve (AGV), the Ahmed ClearPath system (ACP), and the KDB GLIDE. This certification marks a successful transition from the previous Medical Device Directive (MDD) requirements, underscoring New World Medical's commitment to advancing glaucoma management.

About the Certification

The successful acquisition of MDR certification is essential for companies operating in the healthcare and medical sector, especially for those involved in devices that treat chronic conditions like glaucoma. These products were already available in the European market under the MDD but now comply with the more rigorous regulatory framework set forth by the EU.

Raymond Kong, New World Medical's Chief Commercial Officer, expressed pride in achieving this milestone. He stated, “The MDR certification is a testament to our team's hard work and collaboration, enabling us to continue providing specialized glaucoma surgeons in Europe with innovative solutions.” This approval not only enhances confidence among medical practitioners but also expands treatment options available to patients suffering from glaucoma.

Future Aspirations

Looking ahead, New World Medical has plans to apply MDR certification to other products in its portfolio. The company has identified the Ahmed ClearPath ST (ACP ST) as a priority, a device already recognized in over 20 countries as a trusted therapeutic option for treating refractory glaucoma.

Kong noted the growing interest among European surgeons in ACP ST, referring to it as “a next-generation glaucoma drainage device designed to offer greater surgical flexibility.” Achieving MDR certification for the ACP represents a substantial advancement in New World Medical's European growth strategy, laying a regulatory foundation for future developments in the Ahmed ClearPath product line, including ACP ST.

Commitment to Innovation

This milestone further strengthens New World Medical's global portfolio within the glaucoma field. The company is dedicated to preserving and improving vision, ensuring that innovative solutions remain accessible to patients globally. Founded by Dr. A. Mateen Ahmed, New World Medical continues to focus on humanity's well-being through the development of pioneering surgical devices aimed at glaucoma treatment.

Their product range includes the market-leading Ahmed Glaucoma Valve, the Ahmed ClearPath system, the KDB GLIDE, the STREAMLINE surgical system, and the VIA360 surgical system.

For more information about New World Medical and its innovative products, visit New World Medical's website.